Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Unknown 3Not yet recruiting 2Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 2

Conditions

Breast Neoplasms 6Triple Negative Breast Neoplasms 4Non-Muscle Invasive Bladder Neoplasms 2Wilms Tumor 1Urinary Bladder Neoplasms 1Sarcoma 1Rare Tumour 1Osteosarcoma 1Carcinoma, Adenoid Cystic 1

Interventions

Gemcitabine 6Radiotherapy 4Mitomycin 3Epirubicin 2toripalimab 1tislelizumab 1pirarubicin 1hydroxycamptothecinum 1Watchful Waiting 1Maintenance 1Injections 1Docetaxel 1BCG Vaccine 1Anesthesia, Spinal 1Anesthesia, General 1ALT-803 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Non-Muscle Invasive Bladder Neoplasms × Epirubicin × Clear all
NCT07424287 2026-06-02

A Study of Intravesical SHR-1501 Combination With BCG Versus Investigator-selected Chemotherapy in Subjects With BCG-unresponsive NMIBC

Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Phase 3 Not yet recruiting
236 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms

NCT06227065 2024-01-26

POLO

University of Bern

Phase 2 Not yet recruiting
28 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡